Lord Abbett Micro Cap Growth C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Lord Abbett Micro Cap Growth Fund Class C LCMGX
- NAV / 1-Day Return $24.99 / −2.65 %
- Fund Size $182.0M
- Adjusted Expense Ratio 2.120%
- Net Expense Ratio 2.120%
- Fee Level: Distribution Above Average
- Share Class Type Level Load
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $1,500
- Investment Status Limited
- TTM Yield 0.00%
- Turnover Ratio 107%
Morningstar’s Analysis LCMGX
Will LCMGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Adaptive Biotechnologies Corp | 2.98 | 6M | Healthcare |
Aehr Test Systems | 2.65 | 5M | Technology |
Enliven Therapeutics Inc | 2.54 | 5M | Healthcare |
Red Violet Inc Ordinary Shares | 2.22 | 5M | Technology |
CECO Environmental Corp | 2.21 | 5M | Industrials |
Nurix Therapeutics Inc Ordinary Shares | 2.05 | 4M | Healthcare |
Imax Corp | 2.03 | 4M | Communication Services |
MBX Biosciences Inc | 1.98 | 4M | Healthcare |
Lindblad Expeditions Holdings Inc | 1.96 | 4M | Consumer Cyclical |
CareDx Inc | 1.92 | 4M | Healthcare |